Suppr超能文献

在接触米托蒽醌后建立多药耐药性过程中ABC转运蛋白Mdr1/P-gp(Abcb1)、mrpl(Abcc1)和bcrp(Abcg2)的诱导。

Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone.

作者信息

Nieth C, Lage H

机构信息

Charité Campus Mitte, Institute of Pathology, Schumannstr. 20/21, D-10117 Berlin, Germany.

出版信息

J Chemother. 2005 Apr;17(2):215-23. doi: 10.1179/joc.2005.17.2.215.

Abstract

Resistance to mitoxantrone is often associated with enhanced drug efflux mediated by members of the superfamily of adenosinetriphosphate-binding cassette (ABC) transporters, i.e. MDR1/P-gp (ABCB1), MRP1 (ABCC1), or BCRP (ABCG2). So far it is unclear whether the same ABC-transporter is always activated from the beginning of mitoxantrone treatment to the end of drug exposure. Here, we demonstrate that the expression of all three extrusion pumps is induced by increasing levels of mitoxantrone resistance, but in the end, merely the overexpression of a dominant single drug transporter, i.e. Mdr1/P-gp, is realized. This upregulation of Mdr1/P-gp was reflected by amplification of the Mdr1/P-gp encoding gene. Short mitoxantrone exposure demonstrated that upregulation of two different transporters, Mdr1/P-gp and Bcrp, was induced. The data indicate that mitoxantrone treatment influences the expression of several ABC-transporters, but in the end, merely a single extrusion pump will be dominant.

摘要

对米托蒽醌的耐药性通常与三磷酸腺苷结合盒(ABC)转运蛋白超家族成员介导的药物外排增强有关,即多药耐药蛋白1/ P-糖蛋白(MDR1/P-gp,ABCB1)、多药耐药相关蛋白1(MRP1,ABCC1)或乳腺癌耐药蛋白(BCRP,ABCG2)。到目前为止,尚不清楚从米托蒽醌治疗开始到药物暴露结束是否总是激活相同的ABC转运蛋白。在此,我们证明所有三种外排泵的表达均随着米托蒽醌耐药水平的升高而诱导,但最终仅实现了一种主要单一药物转运蛋白即Mdr1/P-gp的过表达。Mdr1/P-gp的这种上调通过Mdr1/P-gp编码基因的扩增得以体现。短期米托蒽醌暴露表明,Mdr1/P-gp和Bcrp这两种不同转运蛋白的上调被诱导。数据表明,米托蒽醌治疗会影响几种ABC转运蛋白的表达,但最终只有一种外排泵占主导地位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验